{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:02Z","timestamp":1790741582569,"version":"4.1.0"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070871"],"award-info":[{"award-number":["82070871"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370861"],"award-info":[{"award-number":["82370861"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    Obesity-related metabolic diseases are characterized by profound disturbances in glucose and lipid metabolism across multiple organs, yet the mediators that coordinate these tissue-specific alterations remain incompletely understood. Insulin-like growth factor-binding protein 2 (IGFBP2), a circulating and locally expressed regulatory protein, has emerged as a context-dependent modulator of metabolic homeostasis with potential relevance to obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and metabolic dysfunction-associated steatotic liver disease (MASLD). In this review, we integrate evidence from\n                    <jats:italic>in vitro<\/jats:italic>\n                    studies, animal models, and human investigations to examine the tissue-specific roles of IGFBP2 in the liver, adipose tissue, pancreas, skeletal muscle, and cardiovascular system. We further discuss IGFBP2 within an autocrine, paracrine, and endocrine framework, with emphasis on its effects on glucose handling, lipid metabolism, insulin sensitivity, and metabolic adaptation in obesity-related disease states. In addition, we summarize current clinical evidence supporting circulating IGFBP2 as a candidate biomarker of metabolic dysfunction and discuss how nutritional factors and metabolic interventions may influence its expression and circulating levels. Collectively, available evidence suggests that IGFBP2 is a context-dependent regulator and potential translational indicator of metabolic dysregulation; however, important gaps remain regarding its tissue-specific sources and modes of action, receptor interactions, context-specific signaling mechanisms, and the strength of prospective human evidence.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2026.1814752","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:35:12Z","timestamp":1776749712000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Tissue-specific roles of IGFBP2 in glucose and lipid metabolism in obesity-related metabolic diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoyu","family":"Song","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","volume-title":"Global Burden of Disease 2021: Findings From the GBD 2021 Study.","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review.","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease.","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019.","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2518797","DOI":"10.1080\/23288604.2025.2518797","article-title":"Overweight, obesity and diabetes: global trends and a better future?","volume":"11","author":"McPake","year":"2025","journal-title":"Health Syst Reform."},{"key":"B6","volume-title":"One in Eight People are now Living with Obesity.","year":"2024"},{"key":"B7","volume-title":"IDF Diabetes Atlas teB.","year":"2025"},{"key":"B8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients wwith NAFLD.","volume":"80","author":"De","year":"2024","journal-title":"J Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s43556-025-00303-5","article-title":"Metabolic syndrome: molecular mechanisms and therapeutic interventions.","volume":"6","author":"Zheng","year":"2025","journal-title":"Mol Biomed."},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cld.2023.01.002","article-title":"Metabolic syndrome and its association with nonalcoholic steatohepatitis.","volume":"27","author":"Bril","year":"2023","journal-title":"Clin Liver Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders.","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity."},{"key":"B13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","article-title":"Adipose tissue fibrosis in obesity: etiology and challenges.","volume":"84","author":"Marcelin","year":"2022","journal-title":"Annu Rev Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018.","volume":"41","year":"2018","journal-title":"Diabetes Care."},{"key":"B16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00535-018-1451-5","article-title":"To die or not to die: death signaling in nonalcoholic fatty liver disease.","volume":"53","author":"Akazawa","year":"2018","journal-title":"J Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/jim-2019-001186","article-title":"Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy.","volume":"68","author":"Sattari","year":"2020","journal-title":"J Investig Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.","volume":"31","author":"Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.5604\/01.3001.0012.0922","article-title":"Impact of diabetes mellitus and insulin on nonalcoholic fatty liver disease in the morbidly obese.","volume":"17","author":"Strey","year":"2018","journal-title":"Ann Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes.","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e240115","DOI":"10.1530\/JOE-24-0115","article-title":"The role of adipose tissue dysfunction in hepatic insulin resistance and T2D.","volume":"262","author":"Sancar","year":"2024","journal-title":"J Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7570\/jomes24013","article-title":"Understanding adipose tissue dysfunction.","volume":"33","author":"Bl\u00fcher","year":"2024","journal-title":"J Obes Metab Syndr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13238","DOI":"10.3390\/ijms252413238","article-title":"The causal role of ectopic fat deposition in the pathogenesis of metabolic syndrome.","volume":"25","author":"Janssen","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbalip.2009.09.011","article-title":"Mitochondrial dysfunction and lipotoxicity.","volume":"1801","author":"Schrauwen","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/BJ20141248","article-title":"Regulation of IGFBP-2 expression during fasting.","volume":"467","author":"Kang","year":"2015","journal-title":"Biochem J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1210\/en.2013-2099","article-title":"Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models.","volume":"155","author":"Yau","year":"2014","journal-title":"Endocrinology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene.","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"109159","DOI":"10.1016\/j.jnutbio.2022.109159","article-title":"Adipose extracellular matrix deposition is an indicator of obesity and metabolic disorders.","volume":"111","author":"Chen","year":"2023","journal-title":"J Nutr Biochem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ijo.2014.192","article-title":"IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes.","volume":"39","author":"Yau","year":"2015","journal-title":"Int J Obes."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3035184","DOI":"10.1155\/2017\/3035184","article-title":"Insulin-Like Growth Factor (IGF) binding Protein-2, independently of IGF-1, induces GLUT-4 translocation and glucose uptake in 3T3-L1 adipocytes.","volume":"2017","author":"Assefa","year":"2017","journal-title":"Oxid Med Cell Longev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"102026","DOI":"10.1016\/j.molmet.2024.102026","article-title":"IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFR-STAT3 pathway.","volume":"89","author":"Zhai","year":"2024","journal-title":"Mol Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.atherosclerosis.2014.09.022","article-title":"Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides.","volume":"237","author":"Carter","year":"2014","journal-title":"Atherosclerosis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2337\/db18-0620","article-title":"Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the risk of developing Type 2 Diabetes.","volume":"68","author":"Wittenbecher","year":"2019","journal-title":"Diabetes."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1092307","DOI":"10.3389\/fendo.2022.1092307","article-title":"Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes.","volume":"13","author":"Brismar","year":"2022","journal-title":"Front Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E409","DOI":"10.1152\/ajpendo.00168.2015","article-title":"The RGD sequence present in IGFBP-2 is required for reduced glucose clearance after oral glucose administration in female transgenic mice.","volume":"309","author":"Reyer","year":"2015","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cytogfr.2014.12.001","article-title":"IGFBP-2: the dark horse in metabolism and cancer.","volume":"26","author":"Russo","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12031-015-0589-3","article-title":"Insulin-Like growth factor binding Protein-2 promotes adhesion of endothelial progenitor cells to endothelial cells via integrin \u03b15\u03b21.","volume":"57","author":"Feng","year":"2015","journal-title":"J Mol Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e2101088","DOI":"10.1002\/mnfr.202101088","article-title":"High-Fat-Diet-Induced extracellular matrix deposition regulates Integrin-FAK signals in adipose tissue to promote obesity.","volume":"66","author":"Chen","year":"2022","journal-title":"Mol Nutr Food Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1210\/en.2005-0467","article-title":"Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion.","volume":"146","author":"Russo","year":"2005","journal-title":"Endocrinology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1530\/ERC-13-0077","article-title":"Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2.","volume":"20","author":"Biernacka","year":"2013","journal-title":"Endocr Relat Cancer."},{"key":"B42","doi-asserted-by":"publisher","first-page":"qzaf029","DOI":"10.1093\/gpbjnl\/qzaf029","article-title":"Glycolysis induces abnormal transcription through histone lactylation in t-cell acute lymphoblastic leukemia.","volume":"23","author":"Wu","year":"2025","journal-title":"Genom Proteom Bioinform."},{"key":"B43","doi-asserted-by":"publisher","first-page":"12016","DOI":"10.1038\/s41598-017-12191-z","article-title":"Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.","volume":"7","author":"Katayama","year":"2017","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"138537","DOI":"10.1016\/j.ijbiomac.2024.138537","article-title":"Role of miRNA regulation in IGFBP-2 overexpression and neuronal ferroptosis: insights into the Nrf2\/SLC7A11\/GPX4 pathway in Alzheimer\u2019s disease.","volume":"287","author":"Luo","year":"2025","journal-title":"Int J Biol Macromol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/bjc.2011.127","article-title":"Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel.","volume":"104","author":"Uzoh","year":"2011","journal-title":"Br J Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fendo.2019.00822","article-title":"IGFBP-2 signaling in the brain: from brain development to higher order brain functions.","volume":"10","author":"Khan","year":"2019","journal-title":"Front Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/ijms22031133","article-title":"Potential role of insulin growth-factor-binding Protein 2 as therapeutic target for obesity-related insulin resistance.","volume":"22","author":"Boughanem","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1210\/en.2013-1622","article-title":"IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob\/ob mice.","volume":"155","author":"Neumann","year":"2014","journal-title":"Endocrinology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2337\/db06-0436","article-title":"IGF-binding protein-2 protects against the development of obesity and insulin resistance.","volume":"56","author":"Wheatcroft","year":"2007","journal-title":"Diabetes."},{"key":"B50","doi-asserted-by":"publisher","first-page":"E723","DOI":"10.1152\/ajpendo.00555.2018","article-title":"Downregulation of microRNA-873 attenuates insulin resistance and myocardial injury in rats with gestational diabetes mellitus by upregulating IGFBP2.","volume":"318","author":"Han","year":"2020","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e22881","DOI":"10.1096\/fj.202201950R","article-title":"FGF1 ameliorates obesity-associated hepatic steatosis by reversing IGFBP2 hypermethylation.","volume":"37","author":"Wang","year":"2023","journal-title":"FASEB J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.numecd.2008.12.011","article-title":"Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects.","volume":"19","author":"Succurro","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","article-title":"Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.","volume":"359","author":"Sandhu","year":"2002","journal-title":"Lancet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1530\/EJE-10-0963","article-title":"Prediction of incident diabetes mellitus by baseline IGF1 levels.","volume":"164","author":"Schneider","year":"2011","journal-title":"Eur J Endocrinol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/diabetes.50.3.637","article-title":"A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction.","volume":"50","author":"Vaessen","year":"2001","journal-title":"Diabetes."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2337\/diabetes.52.6.1403","article-title":"Low circulating IGF-II concentrations predict weight gain and obesity in humans.","volume":"52","author":"Sandhu","year":"2003","journal-title":"Diabetes."},{"key":"B57","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1172\/JCI114797","article-title":"Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.","volume":"86","author":"Zapf","year":"1990","journal-title":"J Clin Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00125-023-05943-2","article-title":"Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4\/F4\/FF4 Study.","volume":"66","author":"Luo","year":"2023","journal-title":"Diabetologia."},{"key":"B59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1530\/EC-12-0053","article-title":"IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes.","volume":"1","author":"Narayanan","year":"2012","journal-title":"Endocr Connect."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/oby.2010.7","article-title":"Adipocytes IGFBP-2 expression in prepubertal obese children.","volume":"18","author":"Claudio","year":"2010","journal-title":"Obesity."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1222101","DOI":"10.3389\/fendo.2023.1222101","article-title":"Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.","volume":"14","author":"Rauzier","year":"2023","journal-title":"Front Endocrinol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cob.12245","article-title":"Serum IGFBP-2 levels are associated with reduced insulin sensitivity in obese children.","volume":"8","author":"Yau","year":"2018","journal-title":"Clin Obes."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1532-5415.2009.02318.x","article-title":"Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study.","volume":"57","author":"Hu","year":"2009","journal-title":"J Am Geriatr Soc."},{"key":"B64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12020-019-01915-y","article-title":"Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects.","volume":"65","author":"Ceccarini","year":"2019","journal-title":"Endocrine."},{"key":"B65","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12876-020-01309-9","article-title":"Effects of gastric sleeve surgery on the serum levels of GH, IGF-1 and IGF-binding protein 2 in healthy obese patients.","volume":"20","author":"Al-Regaiey","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.3390\/ijms21114144","article-title":"Physiological disturbance in fatty liver energy metabolism converges on IGFBP2 abundance and regulation in mice and men.","volume":"21","author":"Fahlbusch","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/ATVBAHA.118.311928","article-title":"Proteins altered by surgical weight loss highlight biomarkers of insulin resistance in the community.","volume":"39","author":"Shah","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6951","DOI":"10.1038\/s41467-021-27289-2","article-title":"High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control.","volume":"12","author":"Dreyfuss","year":"2021","journal-title":"Nat Commun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep4.1940","article-title":"Transcriptomic profiling of a multiethnic pediatric NAFLD cohort reveals genes and pathways associated with disease.","volume":"6","author":"Yao","year":"2022","journal-title":"Hepatol Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41467-025-56695-z","article-title":"Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.","volume":"16","author":"Loesch","year":"2025","journal-title":"Nat Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12884-024-06651-4","article-title":"Prediction of gestational diabetes mellitus by multiple biomarkers at early gestation.","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Pregnancy Childbirth."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1111\/dom.15925","article-title":"Causal relationship between key genes and metabolic dysfunction-associated fatty liver disease risk mediated by immune cells: a Mendelian randomization and mediation analysis.","volume":"26","author":"Feng","year":"2024","journal-title":"Diabetes Obes Metab."},{"key":"B74","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-011-2426-8","article-title":"Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob\/ob mice.","volume":"55","author":"Levi","year":"2012","journal-title":"Diabetologia."},{"key":"B75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.atherosclerosis.2018.12.016","article-title":"Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels.","volume":"281","author":"Carter","year":"2019","journal-title":"Atherosclerosis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.xcrm.2021.100248","article-title":"IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery.","volume":"2","author":"Faramia","year":"2021","journal-title":"Cell Rep Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ghir.2019.03.002","article-title":"Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects.","volume":"45","author":"Zhang","year":"2019","journal-title":"Growth Horm IGF Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ghir.2005.06.013","article-title":"The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.","volume":"15","author":"Hedman","year":"2005","journal-title":"Growth Horm IGF Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/CEJ.0000000000000502","article-title":"Effect of green tea and lycopene on the insulin-like growth factor system: the ProDiet randomized controlled trial.","volume":"28","author":"Biernacka","year":"2019","journal-title":"Eur J Cancer Prev."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.3390\/nu16203476","article-title":"Effect of time-restricted eating on circulating levels of IGF1 and its binding proteins in obesity: an exploratory analysis of a randomized controlled trial.","volume":"16","author":"Akasheh","year":"2024","journal-title":"Nutrients."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/hmg\/ddw121","article-title":"Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice.","volume":"25","author":"Kammel","year":"2016","journal-title":"Hum Mol Genet."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2202976","DOI":"10.1080\/21623945.2023.2202976","article-title":"Adipokines in glucose and lipid metabolism.","volume":"12","author":"Wang","year":"2023","journal-title":"Adipocyte."},{"key":"B83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3803\/EnM.2017.32.1.11","article-title":"Recent insights into insulin-like growth factor binding Protein 2 transcriptional regulation.","volume":"32","author":"Shin","year":"2017","journal-title":"Endocrinol Metab."},{"key":"B84","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.stem.2023.04.007","article-title":"IGFBP2 expressing midlobular hepatocytes preferentially contribute to liver homeostasis and regeneration.","volume":"30","author":"Lin","year":"2023","journal-title":"Cell Stem Cell."},{"key":"B85","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/genes10090706","article-title":"Transcriptional analysis of FOXO1, C\/EBP-\u03b1 and PPAR-\u03b32 genes and their association with obesity-related insulin resistance.","volume":"10","author":"Boughanem","year":"2019","journal-title":"Genes."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1530\/EC-21-0353","article-title":"IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study.","volume":"10","author":"Chen","year":"2021","journal-title":"Endocr Connect."},{"key":"B87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1677\/joe.0.1600305","article-title":"Cellular distribution and ontogeny of Insulin-Like Growth Factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas.","volume":"160","author":"Hill","year":"1999","journal-title":"J Endocrinol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1677\/joe.0.1520455","article-title":"IGF-II, IGF-binding proteins and IGF receptors in pancreatic beta-cell lines.","volume":"152","author":"Katz","year":"1997","journal-title":"J Endocrinol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1258\/ebm.2012.011375","article-title":"Insulin-like growth factor and fibroblast growth factor expression profiles in growth-restricted fetal sheep pancreas.","volume":"237","author":"Chen","year":"2012","journal-title":"Exp Biol Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"110977","DOI":"10.1016\/j.diabres.2023.110977","article-title":"Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2D.","volume":"205","author":"Hjortebjerg","year":"2023","journal-title":"Diabetes Res Clin Pract."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/cancers12051228","article-title":"Role of Tumor and Stroma-Derived IGF\/IGFBPs in Pancreatic Cancer.","volume":"12","author":"Thomas","year":"2020","journal-title":"Cancers."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1210\/en.2012-2162","article-title":"Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton.","volume":"154","author":"Rahman","year":"2013","journal-title":"Endocrinology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"111790","DOI":"10.1016\/j.diabres.2024.111790","article-title":"Proteomics profiling and association with cardiorenal complications in type 2 diabetes subtypes in Asian population.","volume":"214","author":"Gurung","year":"2024","journal-title":"Diabetes Res Clin Pract."},{"key":"B94","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","article-title":"IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis.","volume":"20","author":"Wheatcroft","year":"2009","journal-title":"Trends Endocrinol Metab."},{"key":"B95","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/en.2013-1236","article-title":"The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.","volume":"154","author":"Xi","year":"2013","journal-title":"Endocrinology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cmet.2024.04.017","article-title":"A human omentum-specific mesothelial-like stromal population inhibits adipogenesis through IGFBP2 secretion.","volume":"36","author":"Ferrero","year":"2024","journal-title":"Cell Metab."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0184182","DOI":"10.1371\/journal.pone.0184182","article-title":"IGFBP2 enhances adipogenic differentiation potentials of mesenchymal stem cells from Wharton\u2019s jelly of the umbilical cord via JNK and Akt signaling pathways.","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One."},{"key":"B98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ghir.2013.03.004","article-title":"The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy.","volume":"23","author":"Sharples","year":"2013","journal-title":"Growth Horm IGF Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/cells8040360","article-title":"MiR-34b-5p mediates the proliferation and differentiation of myoblasts by targeting IGFBP2.","volume":"8","author":"Wang","year":"2019","journal-title":"Cells."},{"key":"B100","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/en.2015-1690","article-title":"IGF-I and IGFBP-2 stimulate AMPK activation and autophagy, which are required for osteoblast differentiation.","volume":"157","author":"Xi","year":"2016","journal-title":"Endocrinology."},{"key":"B101","doi-asserted-by":"publisher","first-page":"23232","DOI":"10.1002\/jcp.28890","article-title":"IGFBP-2 stimulates calcium\/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.","volume":"234","author":"Xi","year":"2019","journal-title":"J Cell Physiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2016.07.002","article-title":"Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology.","volume":"3","author":"Swiderski","year":"2016","journal-title":"Growth Horm IGF Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/jcsm.12692","article-title":"Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.","volume":"12","author":"Dong","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis.","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B105","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12916-020-01734-3","article-title":"Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.","volume":"18","author":"Yang","year":"2020","journal-title":"BMC Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41390-020-01113-x","article-title":"Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.","volume":"88","author":"Griffiths","year":"2020","journal-title":"Pediatr Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e12039","DOI":"10.1002\/pul2.12039","article-title":"Proteomics discovery of pulmonary hypertension biomarkers: insulin-like growth factor binding proteins are associated with disease severity.","volume":"12","author":"Nies","year":"2022","journal-title":"Pulm Circ."},{"key":"B108","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in Atherosclerosis regression.","volume":"40","author":"Barrett","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1490387","DOI":"10.3389\/fimmu.2024.1490387","article-title":"Mechanisms and treatment of atherosclerosis: focus on macrophages.","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/cells10010037","article-title":"CD8+ T cells in atherosclerosis.","volume":"10","author":"Sch\u00e4fer","year":"2020","journal-title":"Cells."},{"key":"B112","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis.","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41569-023-00883-1","article-title":"Flow-induced reprogramming of endothelial cells in atherosclerosis.","volume":"20","author":"Tamargo","year":"2023","journal-title":"Nat Rev Cardiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2238959","DOI":"10.1080\/19490976.2023.2238959","article-title":"Protection against metabolic associated fatty liver disease by protocatechuic acid.","volume":"15","author":"Tan","year":"2023","journal-title":"Gut Microbes."},{"key":"B115","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1055\/s-2006-924320","article-title":"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.","volume":"114","author":"Heald","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"B116","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/0004563213499145","article-title":"Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes.","volume":"51","author":"Narayanan","year":"2014","journal-title":"Ann Clin Biochem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"111409","DOI":"10.1016\/j.intimp.2023.111409","article-title":"The effects of IGF-1 and IGFBP-2 treatments on the atherosclerosis in the aorta and the coronary arteries of the high cholesterol diet-fed rabbits.","volume":"127","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12933-024-02274-3","article-title":"Plasma proteome association with coronary heart disease and carotid intima media thickness: results from the KORA F4 study.","volume":"23","author":"Elhadad","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/14017431.2014.891760","article-title":"IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study.","volume":"48","author":"Urbonaviciene","year":"2014","journal-title":"Scand Cardiovasc J."},{"key":"B120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/aje\/kwf160","article-title":"Endogenous hormones and carotid atherosclerosis in elderly men.","volume":"157","author":"van den Beld","year":"2003","journal-title":"Am J Epidemiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1210\/jc.2007-2295","article-title":"Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population.","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1814752\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:35:15Z","timestamp":1776749715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1814752\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":121,"alternative-id":["10.3389\/fnut.2026.1814752"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1814752","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1814752"}}